{rfName}
En

Información del proyecto

ID: HORIZON_HORIZON-MSCA-2023-PF-01-01-101151954

Fecha inicio

01-05-2024

Fecha fin

30-04-2026


Financiación

165 312,96 Euros
(Total amount or amount awarded)

Más información en

Análisis de autorías institucional

Tortosa Manzanares, MariolaInvestigador/aRigotti, ThomasInvestigador/a
Compartir
Proyectos I+D+I y Ayudas
>
Proyecto Competitivo

Enantioselective strategies for the synthesis of phenyl bioisosteres

Investigadores/as: Rigotti, Thomas (Investigador/a); Tortosa Manzanares, Mariola (Investigador/a)

Afiliaciones

Resumen

The obtainment of enantioenriched molecules is of fundamental importance since two enantiomers of the same drug candidate can display completely different biological properties. In recent years, an increasing interest in employing saturated scaffolds has been observed in medicinal chemistry since they provide tridimensionality and well-defined exit vectors that give access to novel unexplored chemical space, leading to a higher success in drug discovery programs. Among them, some polycyclic bridged skeletons have been identified as suitable saturated bioisosteres of aromatic rings which represent the common two-dimensional, flat moieties that are routinely employed in the drug discovery process. The aim of EnantioBioIso is to provide novel enantioselective strategies for the synthesis of phenyl bioisosteres, enabling unprecedented approaches to obtain bridged skeletons that are of fundamental importance for medicinal chemistry. (Summary)
Palabras clave
Asymmetric catalysisBioisosteresDrug discoveryEnantioselective synthesisLewis acid catalysisMedicinal chemistryOrganocatalysisPhotocatalysisTransition metal catalysis

Instituciones participantes

Indicios de calidad

Programa

MSCA Postdoctoral Fellowships 2023; Marie Skłodowska-Curie Actions (MSCA)

Agencias financiadoras

Horizon

Alcance

Unión Europea

Ítems relacionados